In New Zealand, the machinery of pharmaceutical access is quietly being reformed — not through new discoveries, but through the removal of bureaucratic distance between patients and medicines that already exist. Pharmac's mid-September proposal would move four treatments for resistant infections and dangerous blood pressure episodes from case-by-case exception applications onto the standard funded schedule, a shift that asks us to consider how often the barrier to healing is not science, but paperwork. For people with spinal cord injuries managing life-threatening pressure spikes, or those fig
Pharmac proposes streamlined access to medicines for hypertension and resistant infections
People with spinal cord injuries and those with rare multidrug-resistant bacterial infections would gain faster, more consistent access to critical medicines.